MicroRNA-221 targets PTEN to reduce the sensitivity of cervical cancer cells to gefitinib through the PI3K/Akt signaling pathway
出版年份 2015 全文链接
标题
MicroRNA-221 targets PTEN to reduce the sensitivity of cervical cancer cells to gefitinib through the PI3K/Akt signaling pathway
作者
关键词
Cervical cancer, miR-221, Gefitinib, PTEN
出版物
TUMOR BIOLOGY
Volume 37, Issue 3, Pages 3939-3947
出版商
Springer Nature
发表日期
2015-10-19
DOI
10.1007/s13277-015-4247-8
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- MicroRNA-373 functions as an oncogene and targets YOD1 gene in cervical cancer
- (2015) Luo-Qiao Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- A randomized trial comparing concurrent chemoradiotherapy with single-agent cisplatin versus cisplatin plus gemcitabine in patients with advanced cervical cancer: An Asian Gynecologic Oncology Group study
- (2015) Chun-Chieh Wang et al. GYNECOLOGIC ONCOLOGY
- MicroRNA-221 governs tumor suppressor HDAC6 to potentiate malignant progression of liver cancer
- (2015) Hyun Jin Bae et al. JOURNAL OF HEPATOLOGY
- miR-133a inhibits cervical cancer growth by targeting EGFR
- (2015) XUESONG SONG et al. ONCOLOGY REPORTS
- MiR-221/222 promote human glioma cell invasion and angiogenesis by targeting TIMP2
- (2015) Fan Yang et al. TUMOR BIOLOGY
- Role of microRNA221 in regulating normal mammary epithelial hierarchy and breast cancer stem-like cells
- (2015) Jia Ke et al. Oncotarget
- A systematic review comparing cisplatin and carboplatin plus paclitaxel-based chemotherapy for recurrent or metastatic cervical cancer
- (2014) Domenica Lorusso et al. GYNECOLOGIC ONCOLOGY
- Multicenter phase II trial of topotecan, cisplatin and bevacizumab for recurrent or persistent cervical cancer
- (2013) Israel Zighelboim et al. GYNECOLOGIC ONCOLOGY
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A prospective phase II study of topotecan (Hycamtin®) and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer
- (2011) N. Manci et al. GYNECOLOGIC ONCOLOGY
- E-cadherin inhibits tumor cell growth by suppressing PI3K/Akt signaling via β-catenin-Egr1-mediated PTEN expression
- (2011) M-T Lau et al. ONCOGENE
- MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN
- (2010) Zhang Chun-zhi et al. BMC CANCER
- Alternative Splicing of Caspase 9 Is Modulated by the Phosphoinositide 3-Kinase/Akt Pathway via Phosphorylation of SRp30a
- (2010) J. C. Shultz et al. CANCER RESEARCH
- Epidermal Growth Factor Receptor Regulates MT1-MMP and MMP-2 Synthesis in SiHa Cells via Both PI3-K/AKT and MAPK/ERK Pathways
- (2010) Zongfeng Zhang et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Clinical significance of miR-221 and its inverse correlation with p27Kip1 in hepatocellular carcinoma
- (2010) Xinhui Fu et al. MOLECULAR BIOLOGY REPORTS
- miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 Downregulation
- (2009) Michela Garofalo et al. CANCER CELL
- MicroRNAs: Novel regulators in the hallmarks of human cancer
- (2009) Kai Ruan et al. CANCER LETTERS
- Targeting the phosphoinositide 3-kinase pathway in cancer
- (2009) Pixu Liu et al. NATURE REVIEWS DRUG DISCOVERY
- Expression of HER-2 in MCF-7 breast cancer cells modulates anti-apoptotic proteins Survivin and Bcl-2 via the extracellular signal-related kinase (ERK) and phosphoinositide-3 kinase (PI3K) signalling pathways
- (2008) Aisha Siddiqa et al. BMC CANCER
- A phase II trial to evaluate gefitinib as second- or third-line treatment in patients with recurring locoregionally advanced or metastatic cervical cancer
- (2007) A. Goncalves et al. GYNECOLOGIC ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More